BC Environmental and Occupational Health Research Network

CCDR grants seek to foster independent careers in research exploring the basis for differences in breast cancer outcomes and the translation of this research into clinical and public health practice interventions, particularly among junior scientists from populations affected by breast cancer disparities. Disparities research of particular interest in this funding year must be in one of these focus areas: the study of biologic determinants of disparities in breast cancer outcomes; models of clinical care that address the causes of disparities in care and outcomes across population groups; and public health interventions that specifically address the provision of health care services in community settings and associated factors contributing to disparities in breast cancer care and outcomes. All proposed research must have significant potential to lead to reductions in disparities in breast cancer incidence and/or mortality.

Career Catalyst Research (CCR) grants seek to provide unique opportunities for scientists in the early stages of their career to further their research independence by providing support for research exploring important issues and novel approaches that will lead to substantial progress in breast cancer research and reductions in breast cancer incidence and/or mortality within the next decade.

IIR Grants seek to stimulate exploration of important issues and novel approaches that will lead to reductions in breast cancer incidence and/or mortality within the next decade. All proposed research must have significant potential to lead to reductions in breast cancer incidence and/or mortality within the next decade. Research of interest in this funding year must be in one of these focus areas: breast cancer biology; genetics; molecular/genetic epidemiology; prevention; detection; risk assessment; biomarkers of risk, disease burden, and/or treatment response or resistance; novel therapeutics; lifestyle interventions with the potential to affect disease outcomes (e.g., incidence and/or mortality); and novel approaches that enhance understanding of the breast cancer disease process.